We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IBB:NASDAQiShares Biotechnology ETF Analysis

Data as of 2026-08-24 - not real-time

$213.56

Latest Price

2/10Risk

Risk Level: Low

Executive Summary

iShares Biotechnology ETF trades at $213.56, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it gained 11.2%. With RSI at 70.7 the momentum picture is overbought, alongside a bullish MACD signal. Watch $184.25 as support and $217.06 as the nearer resistance level.
The 0.44% expense ratio is competitive for its category, and the fund manages $9.21B in assets.
On a 1-10 scale the risk profile lands at 2 — low. With 30-day volatility of 26.8%, a beta of 0.76 and a maximum drawdown of 9.7%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 4 out of 10.

Top Market Events

Andy Gould, The Motley Fool Jul 10, 2026 0 Key Points - The iShares U.IBB delivered 44% returns in one year but swung 40% lower at its worst.Microsoft and our third-party vendors use cookies to store and access information such as unique IDs and personal...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 70.7 signals overbought conditions
  • Trading above the 200-day average of 174.96

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 70.7 signals overbought conditions
  • Trading above the 200-day average of 174.96

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 70.7 signals overbought conditions
  • 30-day volatility of 26.8%

Key Metrics & Analysis

Fund Metrics

Expense Ratio0.44%
AUM$9.2B
Inception Date2001-02-05
Avg Daily Volume1,771,760
Premium/Discount0.00%
Tracking Error0.00%
Dividend Yield0.22%

Technical Analysis

TrendBullish
RSI70.7
Support$184.25
Resistance$217.06
MA 20$197.34
MA 50$190.37
MA 200$174.96
MACDBullish
VolumeIncreasing
Fear & Greed Index94.41

Risk Assessment

Beta0.76
Volatility26.76%
Sector RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.